Shinhan Private Equity
3
64M
3
0.15
1
- Stages of investment
- Areas of investment
Summary
Shinhan Private Equity appeared to be the VC, which was created in 2004. The fund was located in Asia if to be more exact in South Korea. Shinhan Private Equity appeared to be a CVC structure as part of the corporation. The main department of described VC is located in the Seoul.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Shinhan Private Equity, startups are often financed by Symbiosis Group, SunStates Fund, Shumway Capital. The meaningful sponsors for the fund in investment in the same round are QUAD Investment Management, UTC Investment Co., UBS Oncology Impact Fund.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2019.
Among the most successful fund investment fields, there are Business Development, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline CDNetworks, Vedanta Biosciences, Oncorus Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.15
- Investments by industry
- Biotechnology (2)
- Medical (2)
- Therapeutics (1)
- Business Development (1)
- Drug Discovery (1) Show 5 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vedanta Biosciences | 23 Sep 2019 | Biotechnology, Drug Discovery, Medical, Business Development | Late Stage Venture | 16M | United States, Cambridge, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.